Racial disparities in diabetes prevalence among cancer patients.
cancer
diabetes
health disparities
healthcare
racial disparities
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
11
2022
accepted:
30
12
2022
entrez:
30
1
2023
pubmed:
31
1
2023
medline:
31
1
2023
Statut:
epublish
Résumé
Cancer inequity is one of the most critical public health issues faced by ethnic minorities and people of lower socioeconomic status. The disparate burden of cancer is caused by poor access to care and inadequate delivery of cancer treatment, as well as comorbid and co-occurring conditions. Diabetes is a common and serious comorbid condition of cancer. To better understand diabetes prevalence among diverse cancer patients, this study analyzed and described characteristics of cancer patients with diabetes from local-level Service Planning Area (SPA) data using City of Hope Comprehensive Cancer Center data, and United States national-level data from The National Health Interview Survey. Findings from national level data showed that patients in racial/ethnic minority groups had a higher occurrence of being diagnosed with diabetes, especially for non-Hispanic Blacks (OR=1.76, 95% CI=1.51, 2.03) and Hispanic/Latino individuals (OR=1.34, 95% CI=1.18, 1.52). Cancer patients who are older, ethnic minority, overweight/obese and with lower educational levels were more likely to have co-occurring diabetes. SPA-level patient data found similar results. In response to our findings and other reports, clinicians and health system including health coverage organizations should routinely assess cancer patients for cooccurring chronic illnesses, in particular diabetes. Interventions improving coordinated care that integrates oncology, endocrinology and primary care, targeting cancer patients --especially racial/ethnic minorities, overweight/obese, and older patients who are at increased risk for diabetes -- ought to be considered as best practice Whole Person care. With coordinated care management, ethnic disparities in cancer may be better addressed and reduced. Additionally, policymakers can contribute by enacting policies improving access to and coverage of integrated oncology, chronic disease prevention, and associated specialty care i.e., endocrinology to equalize quality care for ethnic minority, lower educated, overweight/obese and older cancer patients who are more likely to suffer greater comorbidity, and inadequate oncology and coordinated care to reduce disparities.
Identifiants
pubmed: 36713552
doi: 10.3389/fonc.2022.1099566
pmc: PMC9880440
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1099566Subventions
Organisme : NCI NIH HHS
ID : K12 CA001727
Pays : United States
Informations de copyright
Copyright © 2023 Ashing, Song, Jones, Brenner and Samoa.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ. 2015 Jan 02;350:g7607
pubmed: 25555821
Cancers (Basel). 2021 Nov 16;13(22):
pubmed: 34830886
Natl Health Stat Report. 2019 Apr;(123):1-8
pubmed: 31112125
J Clin Med Res. 2018 Dec;10(12):911-919
pubmed: 30425764
Int J Qual Health Care. 2020 Apr 27;32(2):120-125
pubmed: 32277234
Cancer Causes Control. 2020 Dec;31(12):1093-1103
pubmed: 32964365
J Natl Cancer Inst. 2022 Nov 14;114(11):1484-1491
pubmed: 35980163
BMC Cancer. 2020 Jan 28;20(1):2
pubmed: 31987032
J Cancer Surviv. 2014 Jun;8(2):312-8
pubmed: 24473830